In the realm of reproductive health, the in vitro fertilisation (IVF) market sale is poised for a monumental ascent, projected to surge at a robust compound annual growth rate (CAGR) of 9.0% from 2022 to 2032, culminating in a substantial valuation of around US$ 1.6 billion. At the core of this remarkable growth trajectory are …